Vol. 41 No. 2 (2024): April
Original Article

Immune response to SARS-CoV-2 prior to vaccination among healthcare workers from Alto Paraná, Paraguay, a seroepidemiological study

Arturo Ramón Vargas Correa
Facultad de Ciencias de la Salud - Universidad Nacional del Este
Nancy Segovia Coronel
Facultad de Ciencias de la Salud - Universidad Nacional del Este Ministerio de Salud Pública y Bienestar Social. Paraguay
Alexandra Clarissa Bayer
Facultad de Ciencias de la Salud - Universidad Nacional del Este
Eva Fabiana Mereles
Facultad de Ciencias de la Salud - Universidad Nacional del Este Ministerio de Salud Pública y Bienestar Social. Paraguay
Margarita Samudio
Universidad del Pacífico
Andrea Giménez Ayala
Facultad de Ciencias de la Salud - Universidad Nacional del Este
Lorena Santacruz
Facultad de Ciencias de la Salud - Universidad Nacional del Este Ministerio de Salud Pública y Bienestar Social - Paraguay
Maria Leticia Ojeda
Facultad de Ciencias de la Salud - Universidad Nacional del Este Ministerio de Salud Pública y Bienestar Social - Paraguay
Ingrid Espinola
Ministerio de Salud Pública y Bienestar Social - Paraguay
Roxana Jorgge
Ministerio de Salud Pública y Bienestar Social - Paraguay

Published 2024-07-17

How to Cite

1.
Vargas Correa AR, Segovia Coronel N, Bayer AC, Mereles EF, Samudio M, Giménez Ayala A, Santacruz L, Ojeda ML, Espinola I, Jorgge R. Immune response to SARS-CoV-2 prior to vaccination among healthcare workers from Alto Paraná, Paraguay, a seroepidemiological study. Rev. Chilena. Infectol. [Internet]. 2024 Jul. 17 [cited 2026 Mar. 11];41(2). Available from: https://revinf.cl/index.php/revinf/article/view/2024000200239

Abstract

Background: Understanding the behavior of humoral response in COVID-19 continues to be a challenge to produce vaccines that provide long-lasting immunity. Aim: To describe the natural humoral response induced by SARS-CoV-2 among healthcare workers based on epidemiological and clinical profiles. Methods: Cross-sectional study in healthcare workers from public hospitals in the Department of Alto Paraná, Paraguay, 962 participants were recruited through consecutive sampling, using a questionnaire and blood sampling. Antibodies were determined by immunochromatography assay for detection of IgM and IgG and by SARS-CoV-2 IgG anti-spike capture ELISA method and factors associated with seropositivity were evaluated. Results: The overall seropositivity was 36.5% (95% CI: 33.4 – 39.5); 59.3% (n: 571) of respondents reported symptoms compatible with COVID-19 since the start of the pandemic and the date of blood draw, 44% (n: 251) of them tested positive; 10.4% (n: 100) who reported no history of symptoms tested positive. The factors associated with seropositivity were the presence of symptoms (p<0.0001); anosmia (p:0.011); to have a risk factor (p:0.036); working at the Presidente Franco District Hospital (p:0.016). No association with sociodemographic factors was observed. Seroprevalence in symptomatic participants varied according to the time elapsed from the onset of symptoms to serology: 34.3% (<15 days), 58.6 (15 - 90 days), 40.1% (>90 days). Conclusions: Clinical characteristics were mostly associated with seropositivity and seroprevalence in symptomatic participants varied according to the time elapsed from the onset of symptoms to serology.